Keynote: AI in Healthcare & Pharma

AI in Healthcare & Pharma: From Breakthrough Technology to Better Patient Outcomes

Artificial intelligence is transforming healthcare and life sciences, from drug discovery and clinical development to patient support and real-world evidence. This presentation explores where AI is already creating value, the major opportunities for innovation and business growth, and the challenges that remain around trust, ethics, regulation, and adoption. Ultimately, success will be measured not by algorithms, but by meaningful improvements in patient outcomes.

Speaker: Dr. Stamen Popov

Dr. Stamen Popov is a physician and healthcare leader with extensive international experience in the pharmaceutical industry, medical affairs, patient engagement, and healthcare innovation. He has held senior roles across Europe, working at the intersection of science, strategy, and patient-centered healthcare. His interests include artificial intelligence, value-based healthcare, and the future of patient engagement in an increasingly digital world.
Currently, Dr. Stamen Popov is a member and consultant at Cancer Support Switzerland in Geneva. He is a member of the European Society of Medical Oncology (ESMO), the American Association of Cancer Research (AACR), and the Fondation Genevoise pour l’Innovation Technologique (FONGIT).

Programme

Tuesday, 17 November 2026. All times are Geneva local time (Europe/Zurich).

Venue and tickets

In person: MIA / Maison Internationale des Associations, Rue des Savoises 15, 1205 Genève, Switzerland. CHF 5 admission, limited to 50 in-person tickets.
Online: Free, unlimited registration. The livestream link will be added before the event. Join online for the presentation at 19:00.
Registration is automatic. In-person registration is confirmed after payment.